Discovery of Novel Multi-Drug Resistance Gene HA117 in Chronic Myelogenous Leukemia Cell Line K562

Strategic Insights -

Scientists in Chongqing, People's Republic of China, have made a significant discovery in the field of cancer research. They have identified a novel multi-drug resistance gene, HA117, which significantly increases the drug resistance of chronic myelogenous leukemia cell line K562. The researchers found that expression of the HA117 gene led to a significant decrease in drug sensitivity in K562 cells, making them more resistant to multiple types of chemotherapy drugs.

Key Takeaways:

  • The researchers cloned and investigated the function of the novel gene HA117 in multidrug-resistant leukemia cell lines.
  • The HA117 gene was found to increase the drug resistance of K562 cells by decreasing their sensitivity to six different chemotherapy drugs.
  • The researchers used adenovirus vectors to infect K562 cells with the HA117 gene, resulting in increased drug resistance.
  • The study provides evidence that HA117 is a functionally relevant multidrug resistance gene.
  • X.Q. Jin, a researcher from Chongqing Medical University, led the study and published it in the Journal of Experimental & Clinical Cancer Research.

Statistics:

  • The drug sensitivities of K562/Ad-HA117 cells decreased by 4.44, 7.18, 3.01, 9.53, 3.48, and 3.61 times compared to uninfected K562 cells.
  • The multiplicity of infection (MOI) of 100 was found to be the most suitable for infecting K562 cells.
  • The expression of HA117 gene was detected by RTPCR, and it was found that the infected K562 cells produced HA117 mRNA.

Sources:

  • Guo et al. (2009). HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance. Journal of Experimental & Clinical Cancer Research, 28(), 63.
  • Gene Therapy Weekly (2009). Discovery of Novel Multi-Drug Resistance Gene HA117 in Chronic Myelogenous Leukemia Cell Line K562.
  • Biomedical Central Ltd. (Publisher of Journal of Experimental & Clinical Cancer Research).